The paper examines the role of academic scientists as a means to source externally new high-tech ventures and the effects on innovative output and market alliances. Empirical evidence based on a unique dataset of Italian biotech ventures partially support our propositions that new ventures derive benefits by involving academic scientists in the development of innovation. We found that: (i) new biotech firms with academic collaboration tend to have more R&D spending when they have more knowledge base; (ii) academic collaboration is more crucial for products under development than patents; (iii) younger and larger biotech firms are more involved in strategic alliances with customers, while younger and smaller biotech firms are more involved in strategic alliances with other biotech firms.
Does Academic Scientist Really Spur the Gale of Innovation in New High-tech ventures?
TORRISI, BENEDETTO
2009-01-01
Abstract
The paper examines the role of academic scientists as a means to source externally new high-tech ventures and the effects on innovative output and market alliances. Empirical evidence based on a unique dataset of Italian biotech ventures partially support our propositions that new ventures derive benefits by involving academic scientists in the development of innovation. We found that: (i) new biotech firms with academic collaboration tend to have more R&D spending when they have more knowledge base; (ii) academic collaboration is more crucial for products under development than patents; (iii) younger and larger biotech firms are more involved in strategic alliances with customers, while younger and smaller biotech firms are more involved in strategic alliances with other biotech firms.File | Dimensione | Formato | |
---|---|---|---|
2009 BAGLIERI.pdf
solo gestori archivio
Licenza:
Non specificato
Dimensione
129.13 kB
Formato
Adobe PDF
|
129.13 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.